Neurotoxin therapy (Botox, Xeomin, Dysport, or Myobloc) can be used to treat several neurological conditions, including certain movement disorders and pain syndromes. We offer neurotoxin therapy for the following conditions:
Dystonia
Dystonia are involuntary muscle contractions that cause twisting and repetitive movements or abnormal postures and can affect anyone at any age. This medical condition can affect your face, eyes (causing excessive blinking known as blepharospasm), jaw, neck (known as cervical dystonia/spasmodic torticollis), limbs, and trunk.
Secondary dystonia results from degenerative conditions such as Parkinson's disease and brain injury from trauma or other neurologic disorders. As well, environmental factors can be attributed, including medications, toxins, infections, or stroke. Spinal cord injury, head, and peripheral injury are also recognized contributors to dystonia.
Migraine Headaches
Botulinum therapy can treat chronic migraine headaches that are refractory to oral medications.
Drooling
Injections of the salivary gland can help reduce saliva production and help with excessive drooling that can be seen in Parkinson’s disease and a number of other conditions.
Spasticity
Spasticity is when patients experience stiff, often painful limbs due to excessive muscle contractions. Causes include multiple sclerosis, stroke, tumor, and cerebral palsy. Neurotoxin therapy (Botox, Xeomin, Dysport, Myobloc) can help improve range of motion.
Tremor
Tremors are most commonly noticed in the hands and arms, but may affect other body parts, including the neck. Neurotoxin therapy can be very effective in treating tremors.
Other Movement Disorders
- Dystonic tics of the eyes, mouth/lips, tongue, and neck
- Hemifacial spasm
- Tardive dyskinesias/dystonia of the mouth/lips, tongue, and neck
- Teeth grinding/bruxism
Locations
-
Overlook Medical Center
-
Movement Disorders Program
-
Atlantic Neuroscience Institute
99 Beauvoir Avenue
Fifth Floor
Summit, NJ 07901
- 908-522-6144
- Monday through Friday, 8:00am to 4:00pm
-
Atlantic Neuroscience Institute